Clinical trial
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone…
NCT00003903 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00003903 |
|---|---|
| Title | Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer |
| Official title | An Evaluation of the Effect of Androgen Ablation on Bone Resorption in Prostate Cancer Patients |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoporosis, Prostate Cancer |
| Intervention type | Procedure |
| Interventions | management of therapy complications |
| Enrollment | 150 |
| Start date | Jul 1, 1999 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: